Erratum to "Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients"

J Immunol Res. 2017:2017:7869412. doi: 10.1155/2017/7869412. Epub 2017 Aug 20.

Sang Jin Lee^{1

2}, Won Park³, Sung Hwan Park⁴, Seung-Cheol Shim⁵, Han Joo Baek⁶, Dae-Hyun Yoo⁷, Hyun Ah Kim⁸, Soo Kon Lee⁹, Yun Jong Lee¹⁰, Young Eun Park¹¹, Hoon-Suk Cha¹², Jin Kyun Park^{1

2}, Eun Young Lee¹, Eun Bong Lee¹, Yeong Wook Song^{1

2}

¹ Division of Rheumatology, Seoul National University Hospital, Seoul, Republic of Korea.
² Department of Molecular Medicine and Biopharmaceutical Sciences, Graduate School of Convergence Science and Technology and College of Medicine, Medical Research Institute, Seoul National University, Seoul, Republic of Korea.
³ Division of Rheumatology, Inha University Hospital, Incheon, Republic of Korea.
⁴ Division of Rheumatology, The Catholic University of Korea Seoul St. Mary's Hospital, Seoul, Republic of Korea.
⁵ Division of Rheumatology, Eulji University Hospital, Daejeon, Republic of Korea.
⁶ Division of Rheumatology, Gachon University Gil Medical Center, Incheon, Republic of Korea.
⁷ Division of Rheumatology, Hanyang University Medical Center, Seoul, Republic of Korea.
⁸ Division of Rheumatology, Hallym University Medical Center, Anyang, Republic of Korea.
⁹ Division of Rheumatology, Yonsei University Health System, Seoul, Republic of Korea.
¹⁰ Division of Rheumatology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
¹¹ Division of Rheumatology, Pusan National University Hospital, Busan, Republic of Korea.
¹² Division of Rheumatology, Samsung Medical Center, Seoul, Republic of Korea.

Abstract

[This corrects the article DOI: 10.1155/2015/487230.].